delsimet 50mg/850mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - sitagliptin hydrochloride monohydrate; metformin hydrochloride - film coated tablets - 50mg/850mg - sitagliptin hydrochloride monohydrate (8000004805) 54,484mg; metformin hydrochloride (0001115704) 850mg
delsimet 50mg/1000mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - sitagliptin hydrochloride monohydrate; metformin hydrochloride - film coated tablets - 50mg/1000mg - sitagliptin hydrochloride monohydrate (8000004805) 54,484mg; metformin hydrochloride (0001115704) 1000mg
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.
medofed (30mg/1.25mg)/5ml oral solution
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - pseudoephedrine hydrochloride; triprolidine hydrochloride - oral solution - (30mg/1.25mg)/5ml - pseudoephedrine hydrochloride (0000345788) 30mg; triprolidine hydrochloride (0000550709) 1,25mg - pseudoephedrine, combinations
maalox 460mg/400mg oral suspension
sanofi-aventis cyprus ltd - ΥΔΡΟΞΕΊΔΙΟ ΤΟΥ ΜΑΓΝΗΣΊΟΥ, ΥΔΡΟΞΕΊΔΙΟ ΤΟΥ ΑΡΓΙΛΊΟΥ - oral suspension - 460mg/400mg - 0001309428 - magnesium hydroxide - 400 mg; 0021645512 - aluminium hydroxide - 460 mg - combinations
eucreas
novartis europharm limited - vildagliptin, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 και 5. 1 για διαθέσιμα δεδομένα σχετικά με διαφορετικούς συνδυασμούς).
steglujan
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic οξύ, μονοϋδρική φωσφορική σιταγλιπτίνη - Σακχαρώδης διαβήτης τύπου 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - steglujan ενδείκνυται σε ενήλικες ηλικίας 18 ετών και άνω με σακχαρώδη διαβήτη τύπου 2 ως επιπρόσθετο στη δίαιτα και την άσκηση για τη βελτίωση του γλυκαιμικού ελέγχου:όταν η μετφορμίνη και/ή σουλφονυλουρία (su) και ένα από τα monocomponents της steglujan δεν παρέχουν επαρκή γλυκαιμικό έλεγχο. σε ασθενείς που αντιμετωπίζονται ήδη με το συνδυασμό του ertugliflozin και η σιταγλιπτίνη ως ξεχωριστά δισκία.
maymetsi 50mg/850mg film coated tablets
tad pharma gmbh (0000009356) heinz-lohmann-strasse 5, cuxhaven, d-27472 - sitagliptin; metformin hydrochloride - film coated tablets - 50mg/850mg - sitagliptin (0486460326) 50mg; metformin hydrochloride (0001115704) 850mg
maymetsi 50mg/1000mg film coated tablets
tad pharma gmbh (0000009356) heinz-lohmann-strasse 5, cuxhaven, d-27472 - sitagliptin; metformin hydrochloride - film coated tablets - 50mg/1000mg - sitagliptin (0486460326) 50mg; metformin hydrochloride (0001115704) 1000mg